Q. Zheng

Efficacy and Safety of Sequential Different B Cell Antigen-Targeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement

Junhan Yang, Zi-fen Gao, Chunju Zhou, 2021, Blood.

Sequential different B-cell antigen–targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma

Junhan Yang, Yang Liu, Chunju Zhou, 2021, Blood advances.

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Ying Yuan, Fangrong Yan, Jiecheng Zhang, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Complicated pulmonary human coronavirus-NL63 infection after a second allogeneic hematopoietic stem cell transplantation for acute B-lymphocytic leukemia

Tong Wu, Zhihui Li, Q. Zheng, 2021, Medicine.

[Investigation for pathological interpretation criteria and its prognostic value for P53 expression in Chinese diffuse large B-cell lymphoma].

Y. F. Shi, Z. Gao, L. Deng, 2022, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

R. Liu, X. Ke, S. Hou, 2022, Blood advances.

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

Jiecheng Zhang, Xiaoming Feng, Lingling Shan, 2023, Journal of Hematology & Oncology.

Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report

Dong Chen, G. Zhu, Yong-hong Zhang, 2021, World journal of clinical cases.

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.

Xiaoming Feng, B. Deng, Jing Pan, 2023, The Lancet. Oncology.